Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MapLight Therapeutics, Inc. (MPLT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MapLight Therapeutics, Inc. (MPLT), most recent 12 months reported: net loss $229.83M, free cash flow -$175.12M. Latest balance sheet on file: liquid cash $304.73M. From SEC filings. Others in Pharmaceutical Preparations: Milestone Pharmaceuticals Inc. · MOONLAKE IMMUNOTHERAPEUTICS · MINERALYS THERAPEUTICS, INC. · Monopar Therapeutics Inc. · MATINAS BIOPHARMA HOLDINGS, INC. · METAVIA INC. · NovaBridge Biosciences · NewcelX Ltd.

Stock screener

Watchlist